Table 3.
Comparison of clinical and laboratory data between COVID-19 patients with mild-moderate and severe disease severity
| Disease severity | |||
|---|---|---|---|
| Mild to Moderate (N=6) | Severe (N=4) |
P value | |
| Age (Mean ± SD) | 37± 19 | 61± 5 | .045 |
| Male (N, %) | 2 (33%) | 1 (25%) | .778 |
| Comorbidity (N, %) | 1 (17%) | 2 (50%) | .260 |
| Ex-smoker (N, %) | 1 (17%) | 1 (25%) | .747 |
| Laboratory data during hospitalization (Mean ± SD) | |||
| Creatinine, umol/L | 66±15 | 58±16 | .038 |
| Aspartate aminotransferase, U/L | 19± 8 | 24± 9 | .031 |
| Lactate dehydrogenase, U/L | 183± 61 | 238 ± 52 | .002 |
| White blood cell, x 109/L | 4.51± 1.18 | 5.57± 1.99 | .014 |
| Lymphocyte, x 109/L | 1.40 ± 0.54 | 1.18 ± 0.49 | .116 |
| Neutrophil, x 109/L | 2.49 ± 0.90 | 3.82 ± 1.81 | .002 |
| C-Reactive Protein (CRP), mg/dL | 1.65 ± 3.16 | 2.63 ± 3.02 | .231 |
| Elevated CRP (N/total sample, %) | 12/35 (34%) | 22/25 (88%) | <.001 |